[
  {
    "date": "2023-12-30",
    "symbol": "ABOS",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40551",
    "entityregistrantname": "Acumen Pharmaceuticals, Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "36-4108129",
    "entityaddressaddressline1": "427 Park St.",
    "entityaddresscityortown": "Charlottesville",
    "entityaddressstateorprovince": "VA",
    "entityaddresspostalzipcode": 22902,
    "cityareacode": 434,
    "localphonenumber": "297-1000",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "ABOS",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1576885,
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Tysons, Virginia",
    "cashandcashequivalentsatcarryingvalue": 66886000,
    "marketablesecuritiescurrent": 176636000,
    "prepaidexpenseandotherassetscurrent": 3093000,
    "assetscurrent": 246615000,
    "marketablesecuritiesnoncurrent": 62553000,
    "restrictedcash": 233000,
    "propertyplantandequipmentandfinanceleaserightofuseassetafteraccumulateddepreciationandamortization": 122000,
    "operatingleaserightofuseasset": 381000,
    "otherassetsnoncurrent": 221000,
    "assets": 310125000,
    "accountspayablecurrent": 1379000,
    "accruedclinicaltrialexpensescurrent": 4387000,
    "accruedliabilitiescurrent": 6339000,
    "financeleaseliabilitycurrent": 756000,
    "operatingleaseliabilitycurrent": 110000,
    "liabilitiescurrent": 12971000,
    "operatingleaseliabilitynoncurrent": 284000,
    "longtermdebt": 29897000,
    "liabilities": 43152000,
    "commonstockvalue": 6000,
    "additionalpaidincapital": 489453000,
    "retainedearningsaccumulateddeficit": -222798000,
    "accumulatedothercomprehensiveincomelossnetoftax": 312000,
    "stockholdersequity": 266973000,
    "liabilitiesandstockholdersequity": 310125000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 57910461,
    "commonstocksharesoutstanding": 57910461,
    "researchanddevelopmentexpense": 42318000,
    "generalandadministrativeexpense": 18820000,
    "operatingexpenses": 61138000,
    "operatingincomeloss": -61138000,
    "interestincomeoperating": 10791000,
    "embeddedderivativegainlossonembeddedderivativenet": -1360000,
    "interestexpense": 581000,
    "othernonoperatingincomeexpense": -83000,
    "nonoperatingincomeexpense": 8767000,
    "netincomeloss": -52371000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": 1063000,
    "comprehensiveincomenetoftax": -51308000,
    "earningspersharebasic": -1.08,
    "earningspersharediluted": -1.08,
    "weightedaveragenumberofsharesoutstandingbasic": 48609383,
    "weightedaveragenumberofdilutedsharesoutstanding": 48609383,
    "stockissuedduringperiodsharesnewissues": 16774193,
    "stockissuedduringperiodvaluenewissues": 2000,
    "stockissuedduringperiodsharesstockoptionsexercised": 111206,
    "stockissuedduringperiodvaluestockoptionsexercised": 325000,
    "adjustmentstoadditionalpaidincapitalwarrantissued": 1132000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6145000,
    "paymentsofstockissuancecosts": 8096000,
    "depreciation": 61000,
    "sharebasedcompensation": 6145000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 3121000,
    "operatingleaserightofuseassetamortizationexpense": 123000,
    "othernoncashexpenseresearchanddevelopment": 739000,
    "marketablesecuritiesrealizedgainlossexcludingotherthantemporaryimpairments": 11000,
    "othernoncashexpenseinterest": 145000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 369000,
    "increasedecreaseinotheroperatingassets": 70000,
    "increasedecreaseinaccountspayable": -261000,
    "increasedecreaseinaccruedclinicaltrialexpenses": 1670000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 2989000,
    "increasedecreaseinfinanceleaseliability": 17000,
    "increasedecreaseinoperatingleaseliability": -110000,
    "netcashprovidedbyusedinoperatingactivities": -43064000,
    "paymentstoacquiremarketablesecurities": 250634000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 78981000,
    "proceedsfromsaleofpropertyplantandequipment": 3000,
    "paymentstoacquireproductiveassets": 21000,
    "netcashprovidedbyusedininvestingactivities": -171671000,
    "proceedsfromissuanceofcommonstock": 121904000,
    "proceedsfromissuanceofdebt": 30000000,
    "paymentsoffinancingcosts": 476000,
    "proceedsfromstockoptionsexercised": 325000,
    "netcashprovidedbyusedinfinancingactivities": 151753000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -62982000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 67119000,
    "interestpaidnet": 169000,
    "rightofuseassetobtainedinexchangeforfinanceleaseliability": 739000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 399000,
    "noncashissuanceofwarrantwithtermloan": 1132000,
    "supplementalfinancialinformationtextblock": "SUPPLEMENTAL FINANCIAL INFORMATION",
    "emerginggrowthcompanypolicytextblock": "Emerging Growth Company",
    "commonstockwarrantspolicytextblock": "Common Stock WarrantThe Company assesses whether warrants issued require accounting as derivatives. The Company determined that its warrant to purchase Common Stock is not a liability within the scope of ASC 480, Distinguishing Liabilities from Equity, but met the requirements to be classified within stockholders’ equity, as the warrant is indexed to the Company’s own stock and met all of the conditions for equity classification in accordance with ASC 815, Derivatives and Hedging.",
    "disclosureofaccruedexpensesandothercurrentliabilitiestabletextblock": "Accrued expenses and other current liabilities consisted of the following (in thousands): December 31,20232022Compensation and other employee liabilities$3,692 $2,008 Research and development2,186 1,211 Interest249 — Other212 131 Total accrued expenses and other current liabilities$6,339 $3,350",
    "workingcapital": 233600000,
    "proceedsfromdebtnetofissuancecosts": 29500000,
    "cashequivalentsatcarryingvalue": 66200000,
    "propertyplantandequipmentusefullife": "P3Y",
    "numberofoperatingsegments": 1,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7523947,
    "debtsecuritiesavailableforsaleamortizedcostcurrent": 144184000,
    "debtsecuritiesavailableforsaleaccumulatedgrossunrealizedgainbeforetaxcurrent": 97000,
    "debtsecuritiesavailableforsaleaccumulatedgrossunrealizedlossbeforetaxcurrent": 191000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 144090000,
    "debtsecuritiesavailableforsaleamortizedcostnoncurrent": 57240000,
    "debtsecuritiesavailableforsaleaccumulatedgrossunrealizedgainbeforetaxnoncurrent": 320000,
    "debtsecuritiesavailableforsaleaccumulatedgrossunrealizedlossbeforetaxnoncurrent": 15000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 57545000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 238879000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 522000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 212000,
    "availableforsalesecuritiesdebtsecurities": 239189000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12months": 78995000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlosspositionlessthan12monthsaccumulatedloss": 152000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlonger": 12074000,
    "debtsecuritiesavailableforsalecontinuousunrealizedlossposition12monthsorlongeraccumulatedloss": 54000,
    "debtsecuritiesavailableforsaleunrealizedlossposition": 91069000,
    "debtsecuritiesavailableforsaleunrealizedlosspositionaccumulatedloss": 206000,
    "debtsecuritiesavailableforsalecurrentterm": "P1Y",
    "debtsecuritiesavailableforsalenoncurrentterm": "P2Y",
    "debtsecuritiesavailableforsaleunrealizedlosspositionperiod": "P12M",
    "cashandcashequivalentsfairvaluedisclosure": 66207000,
    "investmentsfairvaluedisclosure": 201635000,
    "assetsfairvaluedisclosure": 66207000,
    "embeddedderivativefairvalueofembeddedderivativeliability": 2560000,
    "liabilitiesfairvaluedisclosure": 2560000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 2560000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 1200000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityperiodincreasedecrease": 1360000,
    "embeddedderivativeliabilitymeasurementinput": 2.53,
    "researchanddevelopmentserviceagreementscurrent": 1680000,
    "prepaidinsurancecurrent": 807000,
    "interestreceivablecurrent": 225000,
    "duesandsubscriptionscurrent": 175000,
    "prepaidrawmaterialscurrent": 98000,
    "otherassetscurrent": 108000,
    "employeerelatedliabilitiescurrent": 3692000,
    "researchanddevelopmentliabilitycurrent": 2186000,
    "interestpayablecurrent": 249000,
    "otherliabilitiescurrent": 212000,
    "financeleaseliability": 756000,
    "financeleaseinterestexpense": 17000,
    "financeleaseexpense": 17000,
    "operatingleasecost": 133000,
    "subleaseincome": 5000,
    "operatingleaseexpense": 128000,
    "shorttermleaserentexpense": 15000,
    "leasecost": 160000,
    "operatingleasepayments": 121000,
    "noncashresearchanddevelopmentexpensefinanceleaserightofuseassets": 739000,
    "financeleaseweightedaverageremainingleaseterm1": "P3Y9M18D",
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y",
    "financeleaseweightedaveragediscountratepercent": 0.097,
    "operatingleaseweightedaveragediscountratepercent": 0.097,
    "financeleaseliabilitypaymentsduenexttwelvemonths": 763000,
    "financeleaseliabilitypaymentsdue": 763000,
    "financeleaseliabilityundiscountedexcessamount": 7000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 143000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 155000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 158000,
    "lesseeoperatingleaseliabilitypaymentsdue": 456000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 63000,
    "operatingleaseliability": 393000,
    "debtinstrumentfeeamount": 1635000,
    "debtinstrumentinterestrateeffectivepercentage": 0.143,
    "debtinstrumentcarryingamount": 31635000,
    "debtinstrumentunamortizeddiscount": 4298000,
    "interestexpensedebt": 418000,
    "amortizationofdebtdiscountpremium": 145000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 10104000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 21531000,
    "commonstockandpreferredstocksharesauthorized": 310000000,
    "commonstocknumberofvotingrights": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3231274,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.01,
    "sharebasedpaymentarrangementmaximumthresholdcommonstockissuableonexerciseofincentivestockoptions": 12000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 11773198,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3674730,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardcliffperiod": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 12300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y2M12D",
    "sharebasedpaymentarrangementnonvestedawardnumberofanniversaries": 3,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharesofcommonstockoutstandingmaximum": 800000,
    "allocatedsharebasedcompensationexpense": 4288000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.035,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.047,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2045000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 14489,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 6251,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 4021147,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.01,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.76,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.92,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 8.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 3.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 9004000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 7055000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 328500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 328500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 6.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.11,
    "operatinglosscarryforwards": 67200000,
    "operatinglosscarryforwardssubjecttoexpiration": 6500000,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 60700000,
    "taxcreditcarryforwardamount": 1400000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.025,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.004,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.001,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.005,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.225,
    "deferredtaxassetsoperatinglosscarryforwards": 16555000,
    "deferredtaxassetsinprocessresearchanddevelopment": 13328000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1849000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1350000,
    "deferredtaxassetsintangibleassets": 441000,
    "deferredtaxassetsaccrualsandothertemporarydifferences": 575000,
    "deferredtaxassetsgross": 34098000,
    "deferredtaxassetsvaluationallowance": 33661000,
    "deferredtaxassetsnet": 437000,
    "deferredtaxliabilitiesembeddeddebtderivativeliabilities": 274000,
    "deferredtaxliabilitiesother": 163000,
    "deferredtaxliabilities": 437000
  },
  {
    "date": "2022-12-30",
    "symbol": "ABOS",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2022-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40551",
    "entityregistrantname": "Acumen Pharmaceuticals, Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "36-4108129",
    "entityaddressaddressline1": "427 Park St.",
    "entityaddresscityortown": "Charlottesville",
    "entityaddressstateorprovince": "VA",
    "entityaddresspostalzipcode": 22902,
    "cityareacode": 434,
    "localphonenumber": "297-1000",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "ABOS",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1576885,
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Tysons, Virginia",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 130101000,
    "marketablesecuritiescurrent": 47504000,
    "prepaidexpenseandotherassetscurrent": 2724000,
    "assetscurrent": 180329000,
    "marketablesecuritiesnoncurrent": 15837000,
    "propertyplantandequipmentnet": 165000,
    "operatingleaserightofuseasset": 105000,
    "otherassetsnoncurrent": 151000,
    "assets": 196587000,
    "accountspayablecurrent": 1640000,
    "accruedclinicaltrialexpensescurrent": 2717000,
    "accountspayableandotheraccruedliabilitiescurrent": 3350000,
    "operatingleaseliabilitycurrent": 105000,
    "liabilitiescurrent": 7812000,
    "liabilities": 7812000,
    "commonstockvalue": 4000,
    "additionalpaidincapital": 359949000,
    "retainedearningsaccumulateddeficit": -170427000,
    "aocibeforetaxattributabletoparent": -751000,
    "stockholdersequity": 188775000,
    "liabilitiesandstockholdersequity": 196587000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 41025062,
    "commonstocksharesoutstanding": 41025062,
    "researchanddevelopmentexpense": 32361000,
    "generalandadministrativeexpense": 12876000,
    "operatingexpenses": 45237000,
    "operatingincomeloss": -45237000,
    "interestincomeexpensenonoperatingnet": 2392000,
    "othernonoperatingincomeexpense": -11000,
    "nonoperatingincomeexpense": 2381000,
    "netincomeloss": -42856000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -520000,
    "comprehensiveincomenetoftax": -43376000,
    "earningspersharebasic": -1.06,
    "earningspersharediluted": -1.06,
    "weightedaveragenumberofsharesoutstandingbasic": 40601936,
    "weightedaveragenumberofdilutedsharesoutstanding": 40601936,
    "stockissuedduringperiodsharesnewissues": 422160,
    "stockissuedduringperiodvaluenewissues": 3792000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardcashlessexercisesofcommonstockwarrantsinperiod": 4746,
    "stockissuedduringperiodsharesstockoptionsexercised": 124886,
    "stockissuedduringperiodvaluestockoptionsexercised": 115000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3061000,
    "paymentsofstockissuancecosts": 412000,
    "depreciation": 32000,
    "sharebasedcompensation": 3061000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -487000,
    "operatingleaserightofuseassetamortizationexpense": 137000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1700000,
    "increasedecreaseinotheroperatingassets": 137000,
    "increasedecreaseinaccountspayable": 552000,
    "increasedecreaseinaccruedclinicaltrialexpenses": 2570000,
    "increasedecreaseinoperatingleaseliability": -137000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -562000,
    "netcashprovidedbyusedinoperatingactivities": -35153000,
    "paymentstoacquiremarketablesecurities": 41514000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 80860000,
    "paymentstoacquireproductiveassets": 161000,
    "netcashprovidedbyusedininvestingactivities": 39185000,
    "proceedsfromissuanceofcommonstock": 3792000,
    "proceedsfromstockoptionsexercised": 115000,
    "netcashprovidedbyusedinfinancingactivities": 3907000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 7939000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 242000,
    "workingcapital": 172500000,
    "cashequivalentsatcarryingvalue": 129100000,
    "propertyplantandequipmentusefullife": "P3Y",
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofincomeextensiblelist": "http://www.acumenpharm.com/20221231#FairValueAdjustmentOfPreferredStockTrancheRightsLiabilityAndPreferredStockWarrantLiability",
    "numberofoperatingsegments": 1,
    "operatingleaseliability": 105000,
    "debtsecuritiesavailableforsaleamortizedcostcurrent": 30174000,
    "debtsecuritiesavailableforsaleaccumulatedgrossunrealizedlossbeforetaxcurrent": 249000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 29925000,
    "debtsecuritiesavailableforsaleamortizedcostnoncurrent": 15880000,
    "debtsecuritiesavailableforsaleaccumulatedgrossunrealizedlossbeforetaxnoncurrent": 43000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 15837000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 64092000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 751000,
    "availableforsalesecuritiesdebtsecurities": 63341000,
    "debtsecuritiesavailableforsalecurrentterm": "P1Y",
    "debtsecuritiesavailableforsalenoncurrentterm": "P2Y",
    "debtsecuritiesavailableforsaleunrealizedlosspositionperiod": "P12M",
    "cashandcashequivalentsfairvaluedisclosure": 129100000,
    "investmentsfairvaluedisclosure": 45762000,
    "assetsfairvaluedisclosure": 129100000,
    "prepaidinsurancecurrent": 1106000,
    "researchanddevelopmentserviceagreementscurrent": 1077000,
    "prepaidrawmaterialscurrent": 199000,
    "duesandsubscriptionscurrent": 105000,
    "otherassetscurrent": 237000,
    "researchanddevelopmentliabilitycurrent": 1211000,
    "employeerelatedliabilitiescurrent": 2008000,
    "otherliabilitiescurrent": 131000,
    "subleaseincome": 43000,
    "operatingleasecost": 154000,
    "operatingleaseexpense": 111000,
    "shorttermleaserentexpense": 13000,
    "leasecost": 124000,
    "operatingleasepayments": 154000,
    "operatingleaseweightedaverageremainingleaseterm1": "P0Y8M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.1,
    "lesseeoperatingleaseliabilitypaymentsduenextrollingtwelvemonths": 109000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 4000,
    "proceedsfromissuanceinitialpublicoffering": 75000000,
    "numberoftimestheredeemableconvertiblepreferredstockequaltotheshareissueprice": 2,
    "sharesissuedpricepershare": 7.6,
    "percentageofvotesintermsofshareholdingneededforconversionintopermanentequity": 0.67,
    "commonstocknumberofvotingrights": 1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3326220,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3976237,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 9721945,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardcliffperiod": "P1Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 8900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.017,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1999050,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 79872,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 12277,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 2188874,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.36,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.04,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.93,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.35,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 14980000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 8714000,
    "allocatedsharebasedcompensationexpense": 2163000,
    "operatinglosscarryforwards": 52700000,
    "operatinglosscarryforwardssubjecttoexpiration": 6400000,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 46200000,
    "taxcreditcarryforwardamount": 1400000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.027,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.005,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.011,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.221,
    "deferredtaxassetsoperatinglosscarryforwards": 13125000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1381000,
    "deferredtaxassetsinprocessresearchanddevelopment": 6788000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 675000,
    "deferredtaxassetsaccrualsandothertemporarydifferences": 179000,
    "deferredtaxassetsgross": 22148000,
    "deferredtaxassetsvaluationallowance": 22118000,
    "deferredtaxassetsnet": 30000,
    "deferredtaxliabilitiespropertyplantandequipment": 30000,
    "deferredtaxliabilities": 30000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5610893,
    "cash": 1800000
  },
  {
    "date": "2021-12-30",
    "symbol": "ABOS",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityregistrantname": "Acumen Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1576885,
    "documentannualreport": "true",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40551",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "36-4108129",
    "entityaddressaddressline1": "427 Park St.",
    "entityaddresscityortown": "Charlottesville",
    "entityaddressstateorprovince": "VA",
    "entityaddresspostalzipcode": 22902,
    "cityareacode": 434,
    "localphonenumber": "297-1000",
    "security12btitle": "Common stock, par value $0.0001 per share",
    "tradingsymbol": "ABOS",
    "securityexchangename": "NASDAQ",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "Tysons, Virginia",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "cashandcashequivalentsatcarryingvalue": 122162000,
    "marketablesecuritiescurrent": 72075000,
    "prepaidexpenseandotherassetscurrent": 4424000,
    "assetscurrent": 198661000,
    "marketablesecuritiesnoncurrent": 31619000,
    "propertyplantandequipmentnet": 36000,
    "otherassetsnoncurrent": 14000,
    "assets": 230330000,
    "accountspayablecurrent": 1088000,
    "accountspayableandotheraccruedliabilitiescurrent": 4059000,
    "liabilities": 5147000,
    "commonstockvalue": 4000,
    "additionalpaidincapital": 352981000,
    "retainedearningsaccumulateddeficit": -127571000,
    "aocibeforetaxattributabletoparent": -231000,
    "stockholdersequity": 225183000,
    "liabilitiesandstockholdersequity": 230330000,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 40473270,
    "commonstocksharesoutstanding": 40473270,
    "researchanddevelopmentexpense": 12305000,
    "generalandadministrativeexpense": 7279000,
    "operatingexpenses": 19584000,
    "operatingincomeloss": -19584000,
    "fairvalueadjustmentofpreferredstocktrancherightsliabilityandpreferredstockwarrantliability": 81157000,
    "interestincomeexpensenonoperatingnet": 84000,
    "othernonoperatingincomeexpense": 51000,
    "nonoperatingincomeexpense": -81022000,
    "netincomeloss": -100606000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentbeforetax": -231000,
    "comprehensiveincomeloss": -100837000,
    "earningspersharebasicanddiluted": -5.02,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 20057534,
    "sharesoutstanding": 40473270,
    "temporaryequitystockissuedduringperiodvaluenewissues": 30031000,
    "temporaryequitysharesissuedduringtheperiodshares": 7908027,
    "stockissuedduringperiodvaluepreferredstockwarrantsexercised": 1250000,
    "stockissuedduringperiodsharespreferredstockwarrantsexercised": 447426,
    "reclassificationofpreferredstocktrancherightsliabilityuponissuanceofmilestoneshares": 81190000,
    "reclassificationofwarrantliabilityuponexerciseofpreferredstockwarrant": 5380000,
    "stockissuedduringperiodvaluecommonstockwarrantsexercised": 614000,
    "stockissuedduringperiodsharescommonstockwarrantsexercised": 137446,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -1067000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": -477297,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesnewissues": 11499998,
    "stockissuedduringperiodsharescashlesscommonstockwarrantsexercised": 178847,
    "stockissuedduringperiodvaluestockoptionsexercised": 15000,
    "stockissuedduringperiodsharesstockoptionsexercised": 5183,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -231000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 922000,
    "stockissuancecosts": 16000,
    "depreciation": 4000,
    "sharebasedcompensation": 922000,
    "accretionamortizationofdiscountsandpremiumsinvestments": -155000,
    "othernoncashexpense": 109000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 3881000,
    "increasedecreaseinotheroperatingassets": 14000,
    "increasedecreaseinaccountspayable": 557000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 3636000,
    "netcashprovidedbyusedinoperatingactivities": -17961000,
    "paymentstoacquiremarketablesecurities": 104080000,
    "paymentstoacquireproductiveassets": 40000,
    "netcashprovidedbyusedininvestingactivities": -104120000,
    "proceedsfromissuanceofmilestonesharesnetofissuancecosts": 30031000,
    "proceedsfromwarrantexercises": 1250000,
    "proceedsfromissuanceofcommonstock": 168556000,
    "proceedsfromstockoptionsexercised": 15000,
    "netcashprovidedbyusedinfinancingactivities": 200466000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 78385000,
    "reclassificationofpreferredstocktrancherightsliabilityuponshareissuance": 81190000,
    "conversionofconvertiblepreferredstockintocommonstockuponipo": 174504000,
    "workingcapital": 193500000,
    "cashequivalentsatcarryingvalue": 121200000,
    "propertyplantandequipmentestimatedusefullives": "three",
    "lossduetounreimbursedgrant": 100000,
    "assetsfairvaluedisclosure": 121162000,
    "debtsecuritiesavailableforsaleamortizedcostcurrent": 47939000,
    "availableforsaledebtsecuritiesgrossunrealizedloss": 11000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 47939000,
    "debtsecuritiesavailableforsaleamortizedcostnoncurrent": 16816000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 16713000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 103925000,
    "availableforsalesecuritiesdebtsecurities": 103694000,
    "researchanddevelopmentserviceagreements": 2591000,
    "prepaidinsurance": 1514000,
    "duesandsubscriptionscurrent": 96000,
    "prepaidrawmaterials": 83000,
    "otherprepaidexpensesandothercurrentassets": 140000,
    "researchanddevelopmentliability": 2623000,
    "employeerelatedliabilitiescurrent": 1102000,
    "legalliability": 130000,
    "otheraccruedliabilitiescurrent": 204000,
    "numberoftimestheredeemableconvertiblepreferredstockequaltotheshareissueprice": 2,
    "proceedsfromissuanceinitialpublicoffering": 75000000,
    "sharesissuedpricepershare": 7.6,
    "percentageofvotesintermsofshareholdingneededforconversionintopermanentequity": 0.67,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 5000000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 81190000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitysettlements": -5380000,
    "commonstockvotingrights": "one",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 3857481,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P24M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 4217104,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3475995,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 54000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.013,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2839284,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 1004510,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.51,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 1.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 19458000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 5523000,
    "allocatedsharebasedcompensationexpense": 690000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 40900000,
    "operatinglosscarryforwardsexpirationdate": "2028-12-31",
    "percentagelimitforsetoffnetoperatinglosscarryforwardsgenerationaftertwothousandseventeen": 0.8,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 6400000,
    "operatinglosscarryforwards": 34500000,
    "taxcreditcarryforwardamount": 1400000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 49500000,
    "taxcreditcarryforwardexpirationdate": "2023-12-31",
    "taxcreditcarryforwardlimitationsonuse": "These ownership changes may limit the amount of NOL and R&D credit carryforwards that can be used annually to offset future taxable income and tax, respectively. In general, an “ownership change” as defined by Section 382 of the Code results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50% of the outstanding stock of a company by certain stockholders.",
    "taxcreditcarryforwarddescription": "the Company’s tax years from 2003 and after are subject to examination by the United States and state taxing authorities due to the carry forward of unused NOLs and R&D credits.",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.007,
    "effectiveincometaxratereconciliationchangeinfairvalueoftrancheandwarrantliabilitiespercent": -0.169,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.001,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.003,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.002,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": 0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.043,
    "deferredtaxassetsoperatinglosscarryforwards": 10819000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1381000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 263000,
    "deferredtaxassetsaccrualsandothertemporarydifferences": 58000,
    "deferredtaxassetsgross": 12521000,
    "deferredtaxliabilitydepreciation": -1000,
    "deferredtaxassetsvaluationallowance": 12520000,
    "operatingleaseaggregateminimumrentalspayable": 255000,
    "leaseexpirationdate1": "2023-08-30",
    "operatingleasesfutureminimumpaymentsdueintwoyears": 153000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 102000,
    "operatingleasesfutureminimumpaymentsdue": 255000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3835618
  }
]